Faecal microbiota transplantation: a regulatory hurdle?
Abstract During faecal microbiota transplantation, stool from a healthy donor is transplanted to treat a variety of dysbiosis-associated gut diseases. Competent authorities are faced with the challenge to provide adequate regulation. Currently, regulatory harmonization is completely lacking and auth...
Main Authors: | Frederick Verbeke, Yorick Janssens, Evelien Wynendaele, Bart De Spiegeleer |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-11-01
|
Series: | BMC Gastroenterology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12876-017-0687-5 |
Similar Items
-
Successful Fecal Microbiota Transplantation in a Patient with Severe Complicated Clostridium difficile Infection after Liver Transplantation
by: Kai Markus Schneider, et al.
Published: (2018-02-01) -
The role of fecal microbiota transplantation in the therapy of intestinal and extraintestinal diseases: The basics for health professionals
by: Aleksandra Kwiatkowska, et al.
Published: (2019-06-01) -
Successful Experience of Fecal Transplantation in a Patient with Severe Pseudomembranous Colitis
by: L. R. Shedoeva, et al.
Published: (2021-01-01) -
Faecal microbiota transplantation: A life-saving therapy challenged by commercial claims for exclusivity
by: Christian Lodberg Hvas, et al.
Published: (2020-07-01) -
Faecal Microbiota Transplantation is Effective for the Initial Treatment of Clostridium difficile Infection: A Retrospective Clinical Review
by: Niloufar Roshan, et al.
Published: (2020-09-01)